Volcano Therapeutics formally launched a new intravascular ultrasound imaging catheter at the ACC annual meeting. The Eagle Eye IVUS catheter promises substantially improved near-field and overall image quality with continued effective catheter handling
Volcano Therapeutics formally launched a new intravascular ultrasound imaging catheter at the ACC annual meeting. The Eagle Eye IVUS catheter promises substantially improved near-field and overall image quality with continued effective catheter handling and deliverability. It has been available on a limited basis in the U.S. since late last year and is now available in most major global markets, including Japan and Europe. Eagle Eye works with the company's In-Vision ultrasound console system.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.